Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
ARVEE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.6 pts more than Nifty Microcap 250 and 6.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Arvee Laboratories reported total income of ₹3,219.52 lakhs for FY 2025-26, down from ₹3,914.45 lakhs in the prior year — a revenue decline of approximately 17.5%. However, profit after tax grew to ₹252.63 lakhs from ₹214.74 lakhs in the prior year, an increase of about 17.6%, driven by cost controls and lower raw material consumption (₹1,818.90 lakhs vs ₹1,887.29 lakhs). EPS improved to ₹2.29 per share from ₹1.95. Total equity stands at ₹3,378.77 lakhs. The company operates in two segments: textile and non-textile, with non-textile contributing the majority of revenue (₹2,757.99 lakhs). The auditor issued an unmodified opinion with no qualifications.
Revenue declined year-on-year, which may concern investors, but the profit growth despite lower revenue signals improved operational efficiency. The clean audit opinion is a positive indicator for shareholder confidence.